EMBL VENTURES
EMBL Ventures is a German venture capital engaged in the financing and development of products and technologies in the healthcare sector. EMBL Ventures manages three Funds with a total of 120m capital on behalf of major European private and institutional investors. We prefer a role as lead or co-lead investor in financing rounds which typically range from 5m to 40m. Our total commitment in a single portfolio company can go as high as 10m. As with our portfolio companies each Partner at EMBL Vent... ures strives to build long-lasting personal relationships with Investors in our Funds, such as institutionals, high net-worth individuals and family offices. These relationships are based on EMBL Ventures' core values of open and prompt communication coupled with the ambition to generate maximum return.
EMBL VENTURES
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2001-01-01
Status:
Active
Contact:
+49 (6221) 38933-11
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Apache Wordpress Plugins
Similar Organizations
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-29 | Topas Therapeutics | EMBL Ventures investment in Series B - Topas Therapeutics | 18 M EUR |
| 2020-10-19 | Topas Therapeutics | EMBL Ventures investment in Series B - Topas Therapeutics | 22 M EUR |
| 2018-04-30 | Crescendo Biologics | EMBL Ventures investment in Series B - Crescendo Biologics | 70 M USD |
| 2017-04-26 | Arsanis | EMBL Ventures investment in Series D - Arsanis | 45.5 M USD |
| 2017-01-12 | Luxendo | EMBL Ventures investment in Series A - Luxendo | 8 M EUR |
| 2016-06-15 | Allecra Therapeutics | EMBL Ventures investment in Series B - Allecra Therapeutics | 22 M EUR |
| 2016-03-22 | Topas Therapeutics | EMBL Ventures investment in Series A - Topas Therapeutics | 14 M EUR |
| 2015-10-14 | Luxendo | EMBL Ventures investment in Series A - Luxendo | 6 M EUR |
| 2015-06-24 | Vira Therapeutics | EMBL Ventures investment in Series A - Vira Therapeutics | 3.6 M EUR |
| 2014-10-28 | ImevaX | EMBL Ventures investment in Series A - ImevaX | 7.5 M EUR |